TOPITEN-25
TOPITEN-25 is a clinically proven formulation of Topiramate 25 mg, developed by Felixn Pharmaceuticals to ensure effective control over epileptic seizures and prevention of migraine headaches.
It works by balancing neurotransmitter activity in the brain, reducing abnormal nerve signals, and improving neuronal stability.
TOPITEN-25 provides gentle and reliable therapy, making it suitable for initiation and dose titration in epilepsy and migraine management.
Key Benefits
✅ Effectively controls epileptic seizures and convulsions
✅ Prevents migraine headaches and reduces recurrence
✅ Supports neuronal balance and prevents overactivity in the brain
✅ Provides smooth dose initiation for new patients
✅ Well-tolerated with minimal side effects under medical supervision
Composition (Per Film-Coated Tablet)
Composition (Per Film-Coated Tablet)
Each tablet contains:
- Topiramate I.P. – 25 mg
- Excipients: q.s.
- Colour: Quinoline Yellow
Indications
- Epilepsy & Seizure Disorders (Monotherapy or adjunctive therapy)
- Migraine Prophylaxis
- Bipolar Disorder (Adjunctive Treatment)
- Alcohol Dependence Therapy (as prescribed)
Dosage & Administration
Take one tablet daily, or as directed by your physician.
Swallow whole with water — do not crush or chew.
Dosage may be adjusted gradually based on patient tolerance and response.
Storage
Store in a cool, dry place below 30°C, away from sunlight and moisture.
Keep out of reach of children.
Why Choose TOPITEN-25
- Manufactured under WHO-GMP certified facilities
- Ensures steady absorption and consistent therapeutic effect
- Clinically tested for efficacy and safety in seizure management
- Trusted by neurologists for initial epilepsy therapy and migraine prevention
- Supported by Felixn’s commitment to neurological health